CAS 478837-18-2

8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-hydroxy-,1,1-dimethylethyl ester

Description:

8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester, identified by CAS number 478837-18-2, is a bicyclic compound characterized by its unique azabicyclo structure, which incorporates a nitrogen atom within a bicyclic framework. This compound features a carboxylic acid functional group and an ester moiety, contributing to its chemical reactivity and potential applications in medicinal chemistry. The presence of a hydroxy group enhances its polarity and solubility in polar solvents, while the tert-butyl ester group can influence its lipophilicity and bioavailability. The compound's structural features suggest potential interactions with biological systems, making it of interest in drug development and synthesis. Its stability, reactivity, and specific interactions would depend on the surrounding conditions, such as pH and temperature. Overall, this compound exemplifies the complexity and diversity of bicyclic structures in organic chemistry, with implications for various applications in pharmaceuticals and chemical research.

Formula: C₁₂H₂₁NO₃

tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate

CAS: 478837-18-2

tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate

Purity: 97%

Molecular weight: 227.30g/mol

Ref: 54-OR89974

tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate

CAS: 478837-18-2

Formula: C₁₂H₂₁NO₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 227.304

Ref: 10-F238606

tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate

CAS: 478837-18-2

Tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate is an enhancer of the nicotinic acetylcholine receptor, which is a type of acetylcholine receptor that plays a role in the nervous system. This drug has been shown to be metabolized to α7 nicotinic acetylcholine, which is a profile that enhances cognition and memory. Tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate has putatively been shown to have an antiobesity effect by activating ghrelin receptors and increasing the release of gastric inhibitory polypeptide (GIP).

Formula: C₁₂H₂₁NO₃

Purity: Min. 95%

Molecular weight: 227.3 g/mol

Ref: 3D-DUA83718